A new surgical procedure using a small patch of bovine pericardium to repair the mitral valve shows promise as a safe and effective means of treating ischemic mitral regurgitation. The technique could ...
There is no question MitraClip is an incredibly effective option — more so than expected. Most patients experience a significant decrease in regurgitation, their ventricle shrinks, heart-failure ...
Edwards Lifesciences’ SAPIEN M3 mitral valve replacement system has become the first transcatheter therapy utilizing a transseptal approach to snag FDA approval in the U.S. for the treatment of mitral ...
I have always believed that there are at least 2 mechanisms involved in the production of secondary mitral valve regurgitation. The standard view is that dilation of the left ventricle causes dilation ...
(HealthDay News) – Guidance has been issued relating to transcatheter therapies for mitral regurgitation; the document has been published online Nov. 25 in the Journal of the American College of ...
For years now, cardiology experts have been arguing about how to determine the degree of severity in patients with functional mitral regurgitation and, hence, to assess when it is necessary to operate ...
VANCOUVER, Sept. 23, 2019 /PRNewswire/ - Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement ...
Medical Device Network on MSN
HighLife TMVR system secures CE mark approval for MR treatment
HighLife plans to prioritise procedural consistency and imaging-guided follow-up for safety in early commercial settings.
HighLife announced today that it received CE mark approval for its transcatheter mitral valve replacement (TMVR) system.
Background A 67-year-old man was admitted to a coronary care unit for non-ST-segment elevation myocardial infarction with complicating acute heart failure. Severe mitral regurgitation was detected by ...
HighLife Receives CE Mark Approval for its TMVR SolutionParis, January 26, 2026 – HighLife SAS, a leading MedTech company focused on ...
Data from a 5-year follow-up of outcomes after transcatheter edge-to-edge repair of severe mitral regurgitation, as compared with outcomes after maximal doses of guideline-directed medical therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results